Skip to content
OpenCapital
Get started

Merit Medical Systems MMSI EBITDA margin

EBITDA margin at other companies

Abbott logo
AbbottABT
24.1%-0.2pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
22.1%+0.3pp
TFX
TeleflexTFX
13.6%-10.6pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
34.4%+2.7pp
Stryker logo
StrykerSYK
24.6%+4.7pp
Boston Scientific logo
Boston ScientificBSX
25.2%+1.6pp

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

ebitda/total revenue=20.2%

Based on trailing twelve months.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's EBITDA margin?
Merit Medical Systems (MMSI) reported EBITDA margin of 20.2% in Q1 2026.
How has Merit Medical Systems's EBITDA margin changed year-over-year?
Merit Medical Systems's EBITDA margin increased by 4.4% year-over-year, from 19.4% to 20.2%.
What is the long-term trend for Merit Medical Systems's EBITDA margin?
Over 5 years (2020 to 2025), Merit Medical Systems's EBITDA margin has grown at a 16.2% compound annual growth rate (CAGR), from 9.6% to 20.3%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.